NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00904-7308-61 — Carvedilol 25 mg tabletsAI (511 hospitals, 27,248–27,995 samples)
• NDC 00904-6530-61 — Methadone 10 mg tabletsAI (334 hospitals, 27,425–27,992 samples)
• NDC 00228-2127-50 — Clonidine 0.1 mg tabletAI (162 hospitals, 27,425–27,992 samples)
• NDC 60687-0303-01 — Donepezil 10 mg tablets, 100-count blister packAI (388 hospitals, 27,425–27,992 samples)
• NDC 72205-0003-90 — rosuvastatin 10 mg tabletAI (168 hospitals, 27,425–27,992 samples)
• NDC 68084-0272-01 — Risperidone 1 mg oral tabletsAI (543 hospitals, 27,422–27,989 samples)
• NDC 72485-0613-10 — Ofloxacin eye dropsAI (137 hospitals, 27,025–27,988 samples)
• NDC 65862-0769-90 — Fenofibrate 145 mg tabletsAI (180 hospitals, 27,443–27,983 samples)
• NDC 60687-0496-01 — Amlodipine 10 mg oral tabletsAI (279 hospitals, 27,011–27,983 samples)
• NDC 57664-0477-52 — METOPROLOL TARTRATE 50 MG TABLETAI (165 hospitals, 27,424–27,982 samples)
• NDC 68084-0203-01 — Primidone 250 mg tabletsAI (442 hospitals, 27,501–27,978 samples)
• NDC 64380-0799-01 — OSELTAMIVIR 75 MG CAPSULEAI (567 hospitals, 27,321–27,978 samples)
• NDC 55150-0426-10 — DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTIONAI (52 hospitals, 27,767–27,974 samples)
• NDC 63323-0694-22 — Acetylcysteine 20% solutionAI (165 hospitals, 27,010–27,973 samples)
• NDC 76204-0800-15 — Levalbuterol 0.63 mg per 3 mL nebulizer solutionAI (50 hospitals, 27,010–27,973 samples)
• NDC 60687-0173-57 — Memantine 5 mg tablets, blister packAI (380 hospitals, 27,423–27,972 samples)
• NDC 16729-0203-12 — BUSPIRONE 15 MG TABLETAI (127 hospitals, 27,423–27,972 samples)
• NDC 65862-0186-01 — Clindamycin 300 mg capsulesAI (133 hospitals, 27,423–27,972 samples)
• NDC 00591-4012-01 — valproic acid 250 mg capsuleAI (355 hospitals, 27,423–27,972 samples)
• NDC 50742-0251-90 — Diltiazem extended-release 300 mg capsulesAI (196 hospitals, 27,423–27,972 samples)
• NDC 50742-0251-30 — Diltiazem extended-release 300 mg capsulesAI (130 hospitals, 27,423–27,972 samples)
• NDC 00121-0867-20 — Vancomycin 125 mg capsulesAI (358 hospitals, 27,429–27,969 samples)
• NDC 55150-0202-10 — Pantoprazole sodium 40 mg IV injectionAI (737 hospitals, 26,258–27,968 samples)
• NDC 00409-1582-18 — Bupivacaine 0.75% injectable local anesthetic solutionAI (122 hospitals, 26,202–27,966 samples)
• NDC 55150-0427-10 — DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTIONAI (108 hospitals, 27,766–27,964 samples)
• NDC 00904-7041-61 — Allopurinol 100 mg tabletsAI (618 hospitals, 27,342–27,963 samples)
• NDC 70069-0596-01 — Tetracaine eye dropsAI (58 hospitals, 27,009–27,963 samples)
• NDC 68968-3425-01 — Estradiol 0.025 mg per 24 hours twice-weekly skin patchAI (33 hospitals, 27,009–27,963 samples)
• NDC 00116-4005-11 — Lactulose 10 g/15 mL oral solutionAI (187 hospitals, 27,009–27,963 samples)
• NDC 00116-4005-32 — Lactulose 10 g/15 mL oral solutionAI (54 hospitals, 27,009–27,963 samples)
• NDC 00904-7035-87 — Chlorhexidine 0.12% mouthwashAI (173 hospitals, 27,009–27,963 samples)
• NDC 21922-0063-15 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (76 hospitals, 27,009–27,963 samples)
• NDC 60687-0845-40 — Fluoxetine 20 mg/5 mL oral liquidAI (94 hospitals, 27,009–27,963 samples)
• NDC 60687-0845-77 — Fluoxetine oral liquid, 20 mg per 5 mLAI (111 hospitals, 27,009–27,963 samples)
• NDC 65145-0133-01 — Norepinephrine 1 mg/mL intravenous solutionAI (70 hospitals, 27,009–27,963 samples)
• NDC 65145-0133-10 — Norepinephrine 1 mg/mL intravenous solutionAI (68 hospitals, 27,009–27,963 samples)
• NDC 70069-0311-01 — Polymyxin B and trimethoprim eye dropsAI (165 hospitals, 27,009–27,963 samples)
• NDC 72266-0249-01 — Polymyxin B sulfate injection, 500,000 unitsAI (105 hospitals, 27,009–27,963 samples)
• NDC 50742-0550-01 — Fentanyl 25 mcg/hr skin patchAI (125 hospitals, 27,009–27,963 samples)
• NDC 65145-0130-10 — Rocuronium injection, 10 mg per mLAI (63 hospitals, 27,009–27,963 samples)
• NDC 70756-0608-70 — Formoterol fumarate 20 mcg nebulizer solutionAI (106 hospitals, 27,009–27,963 samples)
• NDC 81033-0020-99 — MUPIROCIN 2 % TOPICAL OINTMENTAI (106 hospitals, 27,009–27,963 samples)
• NDC 81033-0241-51 — Lactulose 10 g/15 mL oral solutionAI (65 hospitals, 27,009–27,963 samples)
• NDC 81033-0241-30 — Lactulose oral solution, 10 g per 15 mLAI (125 hospitals, 27,009–27,963 samples)
• NDC 63323-0695-22 — Acetylcysteine 10% solutionAI (98 hospitals, 27,009–27,963 samples)
• NDC 70069-0020-03 — Acetylcysteine 20% solutionAI (94 hospitals, 27,009–27,963 samples)
• NDC 65145-0130-01 — Rocuronium injection, 10 mg per mLAI (68 hospitals, 27,009–27,963 samples)
• NDC 70069-0020-01 — Acetylcysteine 20% solution (200 mg/mL)AI (73 hospitals, 27,009–27,963 samples)
• NDC 31722-0005-32 — mesalamine 1,000 mg rectal suppositoryAI (99 hospitals, 27,009–27,963 samples)
• NDC 00116-2001-06 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (39 hospitals, 27,009–27,963 samples)